VistaGen Therapeutics
VTGN
VTGN
92 hedge funds and large institutions have $9.13M invested in VistaGen Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
54% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 37
92% less capital invested
Capital invested by funds: $110M → $9.13M (-$101M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
92
Holding in Top 10
–
Calls
$422K
Puts
$19K
Top Buyers
| 1 | +$773K | |
| 2 | +$446K | |
| 3 | +$264K | |
| 4 |
Two Sigma Investments
New York
|
+$121K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$65.8K |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$14.3M | |
| 3 | -$11.5M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$10M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.92M |